A pioneering new drug for multiple myeloma has shown promising results in an early-stage clinical trial, raising hopes for patients with few remaining treatment options. The first-in-class therapy, ...
(InvestigateTV) — Nearly 200,000 people in the United States live with multiple myeloma, a cancer that occurs when a type of white blood cell grows out of control, causing low blood counts, bone and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results